Explore evidence-based medicine therapy practice of acute Guillain-Barre syndrome_Chinese Journal of Evidence-Based Medicine

Authors：

李海峰 ¹ , 袁錦楣 ²

Corresponding?author：

Keywords：

循證醫學; 格林巴利綜合征; 治療

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

目的　通過循證醫學的方法學探討格林-巴林綜合征(GBS)的治療.
方法　采用循證醫學的方法,根據具體病例提出問題,并進行文獻檢索和文獻評價.
結果　根據GBS的激素、血漿置換和免疫球蛋白治療方面的Cochrane證據指導GBS的免疫治療,根據臨床試驗的結果來指導GBS呼吸衰竭等相關問題的處理.
結論　紅循證醫學的指導下能夠更好治療GBS患者,并促進GBS治療研究方法學的提高.

Citation： 李海峰,袁錦楣. Explore evidence-based medicine therapy practice of acute Guillain-Barre syndrome. Chinese Journal of Evidence-Based Medicine, 2003, 03(3): 238-241. doi: Copy

1.	［1］袁錦楣,李海峰格林-巴利綜合征的最新進展[J].中國實用內科雜志2000;20:38-40.
2.	［2］Hughes RA, van Der Meche FG. Corticosteroids for Guillain-Barresyndrome (Cochrane Review)[M/CD]. The Cochrane Library, Issue 1, 2002.
3.	［3］Raphael JC, Chevret S, Hughes RA, et al. Plasma exchange for Guillain-Barre syndrome (Cochrane Review) [M/CD]. The Cochrane Library, Issue 1, 2002.
4.	［4］Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome[J]. Lancet 1997; 349: 225-230.
5.	［5］Wollinsky KH, Hulser PJ, Brinkmeier H, et al. CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial[J]. Neurology 2001; 57: 774-780.
6.	［6］Hughes RA, Raphael .JC, Swan AV, et al. Intravenous immunoglobulin for Guillain-Barre syndrome (Cochrane Review) [M/CD]. The Cochrane Library, Issue 1, 2002.
7.	［7］Sharshar T, ChevretS, Bourdain F, et al. Early predictors of mechanical ventilation in Guillain-Barre syndrome[J]. Crit Care Med 2003;31: 278-283.
8.	［8］Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barre syndrome[J]. Arch Neurol 2001; 58:893-898.
9.	［9］Chevrolet JC, Deleamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barre syndrome[J]. Am Rev Respir Dis 1991;144:814-818.
10.	［10］Wijdicks EFM, Borel CO. Respiratory management in acute neurologic illness[J]. Neurology 1998; 50: 11-20.
11.	［11］Hughes RA. Management of acute neuromuscular paralysis[J]. J R Coll Physicians Lond 1998; 322: 254-259.
12.	［12］Newton-John H. Prevention of pulmonary complications in severe Guillain-Barre syndrome by early assisted ventilation[J]. Med J Aust 1985; 142: 444-445.
13.	［13］Fletcher DD, Lawn ND, Wolter TD, et al. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation[J]. Neurology 2000; 54:2311-2315.
14.	［14］Hughes RA. Systematic reviews of treatment for inflammatory demyelinating neuropathy[J]. JAnat 2002; 200:331-339.
15.	［15］李海峰,叢志強Guillain-Barre綜合征治療進展[J].臨床神經病學雜志2002;15:317-319.
16.	［16］Esperou H, Jars-Guincestre MC, Bolgert F, et al. Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barre syndrome. French Cooperative Group on Plasma Exchange in GuillainBarre Syndrome[J]. Intensive Care Med 2000; 26: 1094-1100.

1. ［1］袁錦楣,李海峰格林-巴利綜合征的最新進展[J].中國實用內科雜志2000;20:38-40.
2. ［2］Hughes RA, van Der Meche FG. Corticosteroids for Guillain-Barresyndrome (Cochrane Review)[M/CD]. The Cochrane Library, Issue 1, 2002.
3. ［3］Raphael JC, Chevret S, Hughes RA, et al. Plasma exchange for Guillain-Barre syndrome (Cochrane Review) [M/CD]. The Cochrane Library, Issue 1, 2002.
4. ［4］Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome[J]. Lancet 1997; 349: 225-230.
5. ［5］Wollinsky KH, Hulser PJ, Brinkmeier H, et al. CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial[J]. Neurology 2001; 57: 774-780.
6. ［6］Hughes RA, Raphael .JC, Swan AV, et al. Intravenous immunoglobulin for Guillain-Barre syndrome (Cochrane Review) [M/CD]. The Cochrane Library, Issue 1, 2002.
7. ［7］Sharshar T, ChevretS, Bourdain F, et al. Early predictors of mechanical ventilation in Guillain-Barre syndrome[J]. Crit Care Med 2003;31: 278-283.
8. ［8］Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barre syndrome[J]. Arch Neurol 2001; 58:893-898.
9. ［9］Chevrolet JC, Deleamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barre syndrome[J]. Am Rev Respir Dis 1991;144:814-818.
10. ［10］Wijdicks EFM, Borel CO. Respiratory management in acute neurologic illness[J]. Neurology 1998; 50: 11-20.
11. ［11］Hughes RA. Management of acute neuromuscular paralysis[J]. J R Coll Physicians Lond 1998; 322: 254-259.
12. ［12］Newton-John H. Prevention of pulmonary complications in severe Guillain-Barre syndrome by early assisted ventilation[J]. Med J Aust 1985; 142: 444-445.
13. ［13］Fletcher DD, Lawn ND, Wolter TD, et al. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation[J]. Neurology 2000; 54:2311-2315.
14. ［14］Hughes RA. Systematic reviews of treatment for inflammatory demyelinating neuropathy[J]. JAnat 2002; 200:331-339.
15. ［15］李海峰,叢志強Guillain-Barre綜合征治療進展[J].臨床神經病學雜志2002;15:317-319.
16. ［16］Esperou H, Jars-Guincestre MC, Bolgert F, et al. Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barre syndrome. French Cooperative Group on Plasma Exchange in GuillainBarre Syndrome[J]. Intensive Care Med 2000; 26: 1094-1100.

Chinese Journal of Evidence-Based Medicine

Explore evidence-based medicine therapy practice of acute Guillain-Barre syndrome

Abstract Full text Figures/Tables Video References Cited by

Format

Content